Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Silk rockets and 3D printing: Researchers looks to transform drug delivery

30-Jun-2016 - Engineers from the University of Sheffield have developed 3D-printed methadone-fuelled silk 'micro-rockets' they say could be used to improve drug delivery.

Magnetically controlled drug dissolves blood clots with fewer side effects

27-Jun-2016 - Researchers have developed a new magnetically controlled drug that can dissolve clots up to 4,000 times more efficiently than ordinary enzyme-based drugs.

Opko extended-release kidney disease drug approved after Catalent 483 delay

22-Jun-2016 - The US FDA has approved Opko Health’s kidney disease drug Rayaldee, delayed by almost three months due to manufacturing concerns at its CMO Catalent.

Collegium's OxyContin rival is first drug using Deterx anti-abuse tech launched in US

21-Jun-2016 - Collegium Pharmaceutical has launched the first product formulated using its Deterx anti-abuse technology in the US.

Valeant commits to Canada with $27.5m manufacturing investment

20-Jun-2016 - Valeant will transfer production tech and modernise a controlled-release finished formulation facility as part of a $27.5m (€24m) investment in its Canadian manufacturing network.

Famar will consider more plant acquisitions in Europe and North America

16-Jun-2016 - Famar has said it will consider buying other US FDA approved facilities in Europe and North America.

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

Famar to buy Spain formulation plant from Roche

15-Jun-2016 - Famar will buy a Roche solid dose manufacturing facility in Spain in an agreement that will also see it make drugs for the Swiss pharmaceutical giant.

UK drug industry output grew in April according to latest ONS data

09-Jun-2016 - The Office for National Statistics has said that overseas demand drove a monthly increase in the volume of pharmaceuticals made in the UK in April. 

Sun sells two more US manufacturing plants

06-Jun-2016 - Sun Pharma has agreed to sell two US oral solid dose manufacturing plants to Frontida BioPharm.

US FDA approved implant offers opioid addicts six-months continuous treatment

02-Jun-2016 - The US FDA has approved Probuphine, a subdermal buprenorphine treatment for opioid dependence using Titan Pharmaceuticals’ ProNeura drug delivery platform.

EU approves second indication for subcutaneous form of Roche's rituximab

01-Jun-2016 - Roche’s subcutaneous formulation of MabThera is about reducing the treatment burden for patients and not protecting it from impending biosimilar competition, the firm says.

Oasmia reviewing proposals from firms interested in API solubility enchancement tech

31-May-2016 - Oasmia Pharmaceutical AB has started reviewing ‘term sheets’ from firms interested in its vitamin A-derived drug delivery tech.

Novo Nordisk and Sanofi diabetes combo drugs receive US recommendation

26-May-2016 - The US FDA has voted in favour of two combination type 2 diabetes drugs putting Novo Nordisk and Sanofi head-to-head in a crowded market.

Combination therapies key to curing cancer, says Pfizer

24-May-2016 - Combination therapies and collaboration will be key in curing cancer, according to Pfizer which has seen 'astounding progress' in its immuno-oncology partnership with Merck KGaA.

New technique creates 'nearly pure drug' for injection

19-May-2016 - Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.

Glide begins solid dose, injectable acromegaly drug trial on birthday of most famous sufferer

19-May-2016 - A solid dose version of the acromegaly treatment octreotide developed by Glide Technologies has entered a proof-of-concept study.

Finished dosage formulations demand driving changes for CMOs

18-May-2016 - As “one of the fastest growing areas in pharma,” the demand for finished dosage formulations is having an impact on several aspects of the CMO industries.

Pfizer, Anacor enter into merger agreement

18-May-2016 - Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for approximately $5.2bn.

Capsugel adds European micro-dosing capacity

16-May-2016 - Rumoured IPO-ready Capsugel has added micro-dose capabilities at its facility in Ploërmel, France citing its acquisition of Xcelience as the driver for the expansion.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation